Becker Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-8,960
Closed -$210K 192
2022
Q3
$210K Sell
8,960
-724
-7% -$21.9K 0.01% 185
2022
Q2
$327K Sell
9,684
-539
-5% -$18.9K 0.02% 167
2022
Q1
$357K Sell
10,223
-1,267
-11% -$43.3K 0.01% 166
2021
Q4
$350K Sell
11,490
-1,287
-10% -$41.9K 0.01% 167
2021
Q3
$419K Sell
12,777
-25,500
-67% -$816K 0.02% 158
2021
Q2
$1.16M Buy
+38,277
New +$1.26M 0.05% 122

Other funds holding OGN

Becker Capital Management's OGN Position: Q4 2022 in Review

Becker Capital Management sold out of Organon & Co (OGN) in Q4 2022, closing a stake of 8,960 shares — an estimated $210K sold.

Becker Capital Management first reported a position in OGN in Q2 2021 and held it in 6 quarters. The position peaked at $1.16M in Q2 2021. 821 funds tracked by Wall St. Rank hold OGN as of Q4 2022.

  • Becker Capital Management reported no remaining Organon & Co position as of Q4 2022 after selling out during the quarter.
  • Becker Capital Management sold 8,960 Organon & Co shares in Q4 2022, an estimated $210K.
  • Becker Capital Management first reported a position in Organon & Co in Q2 2021 and held it in 6 quarters.
  • Becker Capital Management's Organon & Co position peaked at $1.16M in Q2 2021.
  • 821 funds tracked by Wall St. Rank held Organon & Co as of Q4 2022.

Based on Becker Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.